Nexgel, Inc. last reported quarterly results on Aug 17, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): revenue of $3.7 million (+27.8% year over year) and diluted EPS of -$0.40. It usually reports 43–48 days after a quarter ends. Based on that pattern, the next release is estimated for around Nov 11, 2026.
Results for Q3 FY2026, the quarter ending around Sep 30, 2026. Expected on a Wednesday. Based on last year's release for the same quarter on Nov 12, 2025. This is an estimate, not a date the company has announced.
Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 43–48 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.
| Released | Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|---|
|
Aug 17, 2026
48 days after quarter end
|
Q2 FY2026
ended Jun 30, 2026
|
4
+27.8%
|
-4
-446.6%
|
-0.40
-344.4%
|
|
Nov 12, 2025
43 days after quarter end
|
Q3 FY2025
ended Sep 30, 2025
|
3
-0.2%
|
-1
+5.8%
|
-0.08
+27.3%
|
|
Aug 12, 2025
43 days after quarter end
|
Q2 FY2025
ended Jun 30, 2025
|
3
+100.3%
|
-1
+24.9%
|
-0.09
+35.7%
|
|
May 13, 2025
43 days after quarter end
|
Q1 FY2025
ended Mar 31, 2025
|
3
+121.6%
|
-1
+16.5%
|
-0.09
+35.7%
|
|
Jan 22, 2025
22 days after quarter end
|
Q4 FY2024
ended Dec 31, 2024
|
3
+181.1%
|
-1
+22.6%
|
-0.12
+38.6%
|
|
Oct 10, 2024
10 days after quarter end
|
Q3 FY2024
ended Sep 30, 2024
|
3
+140.8%
|
-1
-26.0%
|
-0.11
-10.0%
|
|
Jul 8, 2024
8 days after quarter end
|
—
ended Jun 30, 2024
|
—
|
—
|
—
|
|
Apr 1, 2024
1 days after quarter end
|
—
ended Mar 31, 2024
|
—
|
—
|
—
|
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- NXGL (Nasdaq), NXGLW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Langhorne, PA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1468929
- Former names
- NEXGEL, INC. (until Oct 7, 2026); AquaMed Technologies, Inc. (until Nov 14, 2019)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.